121 related articles for article (PubMed ID: 6974662)
21. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
[TBL] [Abstract][Full Text] [Related]
22. When is systemic antiviral therapy indicated?
Chou S
Int J Dermatol; 1983; 22(1):19-21. PubMed ID: 6299984
[No Abstract] [Full Text] [Related]
23. [Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
Baumann R; Wunderli W; Riess C; Vogt M
Schweiz Med Wochenschr; 1993 Dec; 123(51-52):2394-400. PubMed ID: 8290931
[No Abstract] [Full Text] [Related]
24. Immunotherapy with transfer factor of recurrent herpes simplex type I.
Estrada-Parra S; Chávez-Sánchez R; Ondarza-Aguilera R; Correa-Meza B; Serrano-Miranda E; Monges-Nicolau A; Calva-Pellicer C
Arch Med Res; 1995; 26 Spec No():S87-92. PubMed ID: 8845664
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of cell-mediated immune response in patients with recurrent herpes simplex treated with decaris].
Olszewska Z; Dabkowski R; Kubasiewicz M
Przegl Dermatol; 1988; 75(1):17-23. PubMed ID: 3260388
[No Abstract] [Full Text] [Related]
26. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host.
Meyers JD; Wade JC; Mitchell CD; Saral R; Lietman PS; Durack DT; Levin MJ; Segreti AC; Balfour HH
Am J Med; 1982 Jul; 73(1A):229-35. PubMed ID: 7048914
[TBL] [Abstract][Full Text] [Related]
27. Transfer factor treatment in bullous pemphigoid. Impaired T cell function.
Khan A; Ayyar R; Michaelson JD; Weaver RE; Hill NO
Dermatologica; 1980; 161(4):243-9. PubMed ID: 6157579
[TBL] [Abstract][Full Text] [Related]
28. Use of specific transfer factor for the prevention or the treatment of herpes infections in mice and in man.
Viza D; Vich JM; Phillips J; Davies DA
J Exp Pathol; 1987; 3(4):407-20. PubMed ID: 3454801
[No Abstract] [Full Text] [Related]
29. The alpha-herpesviridae in dermatology : Herpes simplex virus types I and II.
El Hayderi L; Rübben A; Nikkels AF
Hautarzt; 2017 Dec; 68(Suppl 1):1-5. PubMed ID: 28197698
[TBL] [Abstract][Full Text] [Related]
30. Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.
DeMaubeuge J; Haneke E; Djawari D; Wolff K; Stingl G; Molin L; Schöpf E; Stengel R; Degreef H; Panconesi E
Surv Immunol Res; 1985; 4 Suppl 1():30-6. PubMed ID: 2863860
[TBL] [Abstract][Full Text] [Related]
31. Herpes virus-specific immune responses in individuals experiencing recurrent genital herpes.
Boswell CM; Duncan IA; Uttridge J; Sonnex C; Hickling JK
Biochem Soc Trans; 1997 May; 25(2):278S. PubMed ID: 9191322
[No Abstract] [Full Text] [Related]
32. Use of transfer factor for the treatment of recurrent non-bacterial female cystitis (NBRC): a preliminary report.
De Vinci C; Pizza G; Cuzzocrea D; Menniti D; Aiello E; Maver P; Corrado G; Romagnoli P; Dragoni E; LoConte G; Riolo U; Masi M; Severini G; Fornarola V; Viza D
Biotherapy; 1996; 9(1-3):133-8. PubMed ID: 8993771
[TBL] [Abstract][Full Text] [Related]
33. Oral herpes simplex infections in patients with leukemia.
Greenberg MS; Cohen SG; Boosz B; Friedman H
J Am Dent Assoc; 1987 Apr; 114(4):483-6. PubMed ID: 3470373
[TBL] [Abstract][Full Text] [Related]
34. [Antiviral and non-antiviral general treatments for oro-facial and genital herpes (pregnancy and neonates excluded)].
Guillaume JC
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):625-34. PubMed ID: 12122333
[TBL] [Abstract][Full Text] [Related]
35. [Item 84--Herpesvirus infections in the child and the immunocompetent adult: cutaneous and mucosal herpes].
CEDEF
Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A15-21. PubMed ID: 23176837
[No Abstract] [Full Text] [Related]
36. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors.
Khan A; Hill JM; MacLellan A; Loeb E; Hill NO; Thaxton S
Cancer; 1975 Jul; 36(1):86-9. PubMed ID: 1081903
[TBL] [Abstract][Full Text] [Related]
37. [Management of cutaneo-mucosal herpes in immunocompetent patients (ocular manifestations excluded)].
Agence Nationale d' Accréditation et d' Evaluation en Sante'
Presse Med; 2002 Mar; 31(8):363-70. PubMed ID: 11913082
[No Abstract] [Full Text] [Related]
38. Management of oral and genital herpes in the emergency department.
Mell HK
Emerg Med Clin North Am; 2008 May; 26(2):457-73, x. PubMed ID: 18406983
[TBL] [Abstract][Full Text] [Related]
39. Characterization of T cell responses to herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) using a TNF-beta ELISpot cytokine assay.
Schmid DS; Thieme ML; Gary HE; Reeves WC
Arch Virol; 1997; 142(8):1659-71. PubMed ID: 9672626
[TBL] [Abstract][Full Text] [Related]
40. Common questions about herpes simplex.
Feder HM; Renfro L; Schmidt DD
Hosp Pract (Off Ed); 1989 Jan; 24(1A):50-2, 55-6, 61-2. PubMed ID: 2492293
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
